Section 32 Fund 3, LP - Jul 30, 2021 Form 4 Insider Report for DA32 Life Science Tech Acquisition Corp. (DALS)

Role
Director, Director by Deputization, 10%+ Owner
Signature
/s/ Henrikki Harsu, Attorney-in-Fact for Section 32 Fund 3, LP
Stock symbol
DALS
Transactions as of
Jul 30, 2021
Transactions value $
$14,500,000
Form type
4
Date filed
8/3/2021, 09:47 PM
Previous filing
Jul 27, 2021
Next filing
Aug 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DALS Class A Common Stock Purchase $8M +800K $10.00 800K Jul 30, 2021 Direct F1, F2
transaction DALS Class A Common Stock Award $6.5M +650K +81.25% $10.00 1.45M Jul 30, 2021 Through DA32 Sponsor LLC F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Section 32 Fund 3, LP purchased 800,000 shares of the Issuer's Class A common stock for $10.00 per share in the Issuer's initial public offering.
F2 This Form 4 is filed jointly by Section 32 Fund 3, LP ("S32 Fund"), Section 32 GP 3, LLC ("S32 GP") and William J. Maris (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F3 DA32 Sponsor LLC ("Sponsor") purchased 650,000 private placement shares of the Issuer directly from the Issuer for $10.00 per share, concurrently with the Issuer's initial public offering. This purchase was exempted pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended.
F4 Sponsor is the record holder of the securities reported herein. As a managing member of Sponsor, S32 Fund may be deemed to beneficially own the securities owned directly by Sponsor. As the general partner of S32 Fund, S32 GP may be deemed to beneficially own the securities owned directly by Sponsor. As the sole Managing Member of S32 GP, William J. Maris may be deemed to beneficially own securities owned directly by Sponsor.

Remarks:

See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer. Henrikki Harsu, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24.1, 24.2 and 24.3 to a Form 3 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on July 27, 2021 by Section 32 Fund 3, LP, Section 32 GP 3, LLC and William J Maris. Steve Kafka, an employee of Section 32 Fund 3, LP, serves as a director of the Issuer.